Q2 STOCKS TO BUY

Newest Acquisition Has CGC Stock Inching Lower

Earnings are due out from Canopy Growth next Wednesday

Digital Content Manager
Aug 9, 2019 at 10:00 AM
facebook X logo linkedin


Pot name Canopy Growth Corp (NYSE:CGC) announced this morning that it's buying U.K.-based biopharmaceutical company Beckley Canopy Therapeutics for an undisclosed sum, in order to develop weed-based wellness products and strengthen its foothold in Europe. CGC shareholders don't seem too impressed, with the equity down 1% to trade at $32.52.

Despite the slight drop, CGC stock is on pace to end atop its 10-day moving average for a second straight day -- a feat not accomplished in nearly two months. In fact, CGC just hit a seven-month floor of $30.75 earlier this week. Nevertheless, the security is still up almost 22% year-to-date.

Strong earnings could turn the tides for Canopy Growth, with the company's quarterly report set for Wednesday, Aug. 14. The company has only stepped into the earnings confessional two other times since its debut on Wall Street, with the shares suffering a one-day post-earnings loss of 8.1% in June. CGC enjoyed a 3.1% pop the day after its mid-February report. This time around, the options market is pricing in a 10.2% earnings reaction for the shares -- nearly double the average one-day swing.

As far as direction, it looks like options buyers may be bracing for more downside. While long calls are still outnumbering puts on the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), made evident by the stock's 10-day put/call volume of 0.62, this ratio sits higher than 91% of all other reading from the past year. This points to a healthier-than-usual appetite for bearish bets over bullish ahead of Canopy Growth earnings.

In spite of CGC's recent slump, analysts remain hopeful, with 11 of the 15 in coverage calling it a "buy" or better. In the same vein, the security's consensus 12-month price target of $46.50 is at a roughly 42% premium to current levels. Should the firm's earnings disappoint, a round of downgrades or price-target cuts could exacerbate selling pressure on the cannabis concern.

 
 

“Buy This Stock Now!” - Expert Who Called 11x On TSLA

He called a rare 11x on Tesla…

But now, thanks to Elon & Trump’s new alliance…

He says there’s a new opportunity that could be 1,000x BIGGER than Tesla – and it could completely revolutionize a $23 Trillion market.

It’s trading for less than $5 per share right now…

But it won’t be under the radar for long.

Discover The 1,000x Bigger Elon Opportunity Here

GRAND SLAM COUNTDOWN

 
 

Featured Articles from Trusted Partners:

👀Learn How Dividends Create Passive Income for Life
Receive $200 Off Motley Fool Epic. The Motley Fool Epic $299 discounted offer is based on $499/year list price. Introductory promotion for new members only. Take control of your money and your portfolio with Motley Fool Epic.

💵New Income System Could Pay You $4,243 Monthly
You could collect an average of $4,243 per month starting as early as next week with a new payout system for income investors. New registrations are being accepted for investors who want to be in a position to start with their first payout next week.

🚀Easy 92% Crypto Dividends (No Coins Required)
COIN stock doesn't pay a dividend... But there's actually a new way to collect a massive dividend that's indirectly based on the stock and offers a terrific monthly income (currently yielding nearly 92% on a forward basis).

🤝Free Advisor Match with Wiseradvisor.com
Don't leave your retirement to chance! Get matched with a trusted financial expert for FREE and make the most of your tax refund. Get started now.

⚠️Dennis Quaid's #1 Warning for Americans
Here's the thing: life doesn't come with guarantees. The economy shifts, markets stumble, and years of hard work could slip through your fingers like sand. But it doesn't have to be that way for you. So request a free copy of this Gold & Silver Guide that will arrive right to your doorstep when you act now.

 

 
 

Follow us on X, Follow us on Twitter